UNITY Biotechnology, Inc. to Participate in Upcoming Investor Conferences
Tweet
Share
E-mailSAN FRANCISCO, Aug. 27, 2019 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging, today announced that members of its senior management team will participate at the following upcoming investor conferences:
Citi’s 14th Annual Biotech Conference
Date: September 4th, 2019Location: Boston, MA
Morgan Stanley 17th Annual Global Healthcare Conference
Date: September 10th, 2019Presentation Time: 8:40amLocation: New York, NY
A live audio webcast of the presentation at the Morgan Stanley Global Healthcare Conference will be available through the Investors & Media section of UNITY’s website. An archived replay will be available for 90 days following the event.
About UNITY
UNITY is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY's initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases. More information is available at www.unitybiotechnology.com or follow us on Twitter.
Investors Endurance Advisors Peter Rahmer [email protected] Media Jason Spark [email protected]
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
- Asure Software Sets August & September 2026 Investor Conference Schedule
- Plato Gold Reports 2026 Semi-Annual Results, Announces Loan Extensions and Board Update
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Citi, Morgan Stanley, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
